Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisoffi, Zeno, De Santis, Nicoletta, Piubelli, Chiara, Deiana, Michela, Perandin, Francesca, Girardi, Pietro, Heller, Luca, Alba, Natalia, Pomari, Carlo, Guerriero, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045681/
https://www.ncbi.nlm.nih.gov/pubmed/36918375
http://dx.doi.org/10.3201/eid2904.221268
_version_ 1784913663989121024
author Bisoffi, Zeno
De Santis, Nicoletta
Piubelli, Chiara
Deiana, Michela
Perandin, Francesca
Girardi, Pietro
Heller, Luca
Alba, Natalia
Pomari, Carlo
Guerriero, Massimo
author_facet Bisoffi, Zeno
De Santis, Nicoletta
Piubelli, Chiara
Deiana, Michela
Perandin, Francesca
Girardi, Pietro
Heller, Luca
Alba, Natalia
Pomari, Carlo
Guerriero, Massimo
author_sort Bisoffi, Zeno
collection PubMed
description We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified.
format Online
Article
Text
id pubmed-10045681
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-100456812023-04-01 Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022 Bisoffi, Zeno De Santis, Nicoletta Piubelli, Chiara Deiana, Michela Perandin, Francesca Girardi, Pietro Heller, Luca Alba, Natalia Pomari, Carlo Guerriero, Massimo Emerg Infect Dis Dispatch We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified. Centers for Disease Control and Prevention 2023-04 /pmc/articles/PMC10045681/ /pubmed/36918375 http://dx.doi.org/10.3201/eid2904.221268 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Bisoffi, Zeno
De Santis, Nicoletta
Piubelli, Chiara
Deiana, Michela
Perandin, Francesca
Girardi, Pietro
Heller, Luca
Alba, Natalia
Pomari, Carlo
Guerriero, Massimo
Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
title Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
title_full Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
title_fullStr Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
title_full_unstemmed Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
title_short Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
title_sort two-year cohort study of sars-cov-2, verona, italy, 2020‒2022
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045681/
https://www.ncbi.nlm.nih.gov/pubmed/36918375
http://dx.doi.org/10.3201/eid2904.221268
work_keys_str_mv AT bisoffizeno twoyearcohortstudyofsarscov2veronaitaly20202022
AT desantisnicoletta twoyearcohortstudyofsarscov2veronaitaly20202022
AT piubellichiara twoyearcohortstudyofsarscov2veronaitaly20202022
AT deianamichela twoyearcohortstudyofsarscov2veronaitaly20202022
AT perandinfrancesca twoyearcohortstudyofsarscov2veronaitaly20202022
AT girardipietro twoyearcohortstudyofsarscov2veronaitaly20202022
AT hellerluca twoyearcohortstudyofsarscov2veronaitaly20202022
AT albanatalia twoyearcohortstudyofsarscov2veronaitaly20202022
AT pomaricarlo twoyearcohortstudyofsarscov2veronaitaly20202022
AT guerrieromassimo twoyearcohortstudyofsarscov2veronaitaly20202022

Ejemplares similares